Pharma Journalist - Page 119 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

NKGen Biotech Announces Collaboration with the Parkinson’s Foundation to Bring Its Novel Natural Killer Cell Therapy to the Clinic for Advanced Parkinson’s Disease

BeiGene Receives European Commission Approval for BRUKINSA (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma

REITHERA EXPANDS LARGE-SCALE VIRAL VECTOR PRODUCTION CAPABILITIES WITH OPENING OF NEW MANUFACTURING FACILITY

SINOVAC Varicella Vaccine Prequalified by WHO

Evotec completes acquisition of Central Glass Germany

Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline

Vaxzevria receives full Marketing Authorisation in the EU for the prevention of COVID-19

FDA Approves Vemlidy (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients

Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome

Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19